Table 2 .
Clinical characteristics of patients at Uganda Cancer Institute, Luganda language (N = (217) and English language (N = 168)
| Total n (%) |
Luganda n (%) |
English n (%) |
χ2b | Df | P value | |
|---|---|---|---|---|---|---|
| Sample size | 385 (100) | 217 (100) | 168 (100) | |||
| Clinical setting | 0.39 | 1 | 0.533 | |||
| In Patient | 257 (66.8) | 142 (65.4) | 115 (68.5) | |||
| Out Patient | 128 (33.2) | 75 (34.6) | 53 (31.5) | |||
| Cancer type | 11.61 | 9 | 0.236 | |||
| Cervical | 92 (23.9) | 60 (27.6) | 32 (19.0) | |||
| Breast | 68 (17.7) | 32 (14.7) | 36 (21.4) | |||
| KS | 43 (11.2) | 28 (12.9) | 15 (8.9) | |||
| Leukemia | 26 (6.7) | 14 (6.5) | 12 (7.1) | |||
| Prostate | 22 (5.7) | 12 (5.5) | 10 (6.0) | |||
| Oesophageal | 20 (5.2) | 8 (3.7) | 12 (7.1) | |||
| Lymphoma | 18 (4.7) | 7 (3.2) | 11 (6.5) | |||
| Lung | 8 (2.1) | 5 (2.3) | 3 (1.8) | |||
| Ovarian | 8 (2.1) | 4 (1.8) | 4 (2.4) | |||
| Other | 80 (20.8) | 47 (21.7) | 33 (19.6) | |||
| Cancer Stage | 1.39 | 1 | 0.499 | |||
| Early (I & II) | 99 (25.7) | 51 (23.5) | 48 (28.6) | |||
| Late (III & IV) | 208 (54) | 122 (56.2) | 86 (51.2) | |||
| Not reporteda | 78 (20.3) | 44 (20.3) | 34 (20.3) | |||
| Type of treatment | 0.02 | 1 | 0.813 | |||
| Chemotherapy | 235 (61) | 130 (59.9) | 105 (62.5) | |||
| Radiotherapy | 94 (24.4) | 51 (23.5) | 43 (25.6) | |||
| Surgery | 38 (9.9) | 21 (9.7) | 17 (10.1) | |||
| Palliative | 15 (3.9) | 12 (5.5) | 3 (1.8) | |||
| No treatment yet | 3 (< 1) | 3 (< 1) | – | |||
| Grouped KPS | 0.41 | 2 | 0.813 | |||
| ≤ 40 | 58 (15.1) | 34 (15.7) | 24 (14.3) | |||
| 50–70 | 162(42.1) | 93 (42.9) | 69 (41.1) | |||
| ≥ 80 | 165 (42.9) | 90 (41.5) | 75 (44.6) |
DF, Degrees of freedom
aMissing data
bDifferences in proportions tested with χ2 statistics